$2.90
0.16[5.84%]
At close: Apr 24
$2.90
0[0.00%]
After Hours: 7:53AM EDT
LAVA Therapeutics
(NASDAQ:LVTX)Latest News for LAVA Therapeutics Stock (NASDAQ:LVTX)
LAVA Therapeutics Stock (NASDAQ: LVTX)
Categories: All
Thursday, March 21, 2024
Wednesday, March 20, 2024
Tuesday, March 05, 2024
- LAVA Therapeutics shares are trading higher after the company announced a $7 million payment because Pfizer achieved a clinical milestone for PF-08046052.Benzinga Newsdesk - Mar 5, 2024, 7:50AM
- LAVA Therapeutics Announces Pfizer Has Achieved Clinical Development Milestone For PF-08046052, Triggering $7M Payment To LAVABenzinga Newsdesk - Mar 5, 2024, 7:31AM
Thursday, February 29, 2024
- LAVA Therapeutics N.V Filed U.S. Patent Application #20240067726-A1 For "Single Domain Antibodies Targeting CD1D"Benzinga Newsdesk - Feb 29, 2024, 2:24PM
- Watching LAVA Therapeutics N.V.; Shares Spike Higher, Traders Circulate Speculative X Post Rumoring "$PFE Is Going To Talk About $LVTX Partnered EGFR Bispecific. This Stock Pretty Much Forgotten About."Benzinga Newsdesk - Feb 29, 2024, 1:29PM
Friday, January 26, 2024
Thursday, January 25, 2024
- Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Jan 25, 2024, 2:52PM
- Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat ResultsAvi Kapoor - Jan 25, 2024, 1:08PM
- LAVA Therapeutics shares are trading higher after the company announced a clinical trial collaboration and supply agreement with Merck & Co. to evaluate LAVA-1207 in conbination with KEYTRUDA.Benzinga Newsdesk - Jan 25, 2024, 10:48AM
- Dow Surges Over 100 Points; US GDP Growth Tops EstimatesAvi Kapoor - Jan 25, 2024, 10:42AM
- Why Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today?Vandana Singh - Jan 25, 2024, 10:11AM
- Market-Moving News for January 25thBenzinga Newsdesk - Jan 25, 2024, 8:42AM
- LAVA Therapeutics Partners With Merck To Evaluate LAVA-1207 In Combination With KEYTRUDA; No Terms DisclosedBenzinga Newsdesk - Jan 25, 2024, 7:10AM
Friday, November 17, 2023
Thursday, November 16, 2023
Wednesday, August 23, 2023
- What 5 Analyst Ratings Have To Say About LAVA TherapeuticsBenzinga Insights - Aug 23, 2023, 11:00AM
- JMP Securities Reiterates Market Outperform on LAVA Therapeutics, Maintains $6 Price TargetBenzinga Newsdesk - Aug 23, 2023, 8:30AM
- HC Wainwright & Co. Maintains Buy on LAVA Therapeutics, Lowers Price Target to $6Benzinga Newsdesk - Aug 23, 2023, 6:17AM
Tuesday, August 22, 2023
Thursday, June 15, 2023
Wednesday, June 14, 2023
Monday, June 12, 2023
Friday, June 09, 2023
Thursday, June 08, 2023
Friday, June 02, 2023
- Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jun 2, 2023, 1:00PM
- LAVA Therapeutics shares are trading higher after the company announced Janssen selected a lead gamma-delta T cell engager bispecific antibody to move toward clinical development.Benzinga Newsdesk - Jun 2, 2023, 9:34AM
- High-Impact Movers for June 2ndBenzinga Newsdesk - Jun 2, 2023, 8:37AM
- Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving PremarketLisa Levin - Jun 2, 2023, 7:58AM
Thursday, June 01, 2023
Thursday, April 13, 2023
Wednesday, March 15, 2023
Friday, February 17, 2023
Thursday, February 16, 2023
Wednesday, December 14, 2022
Wednesday, November 16, 2022
Tuesday, November 01, 2022
Tuesday, October 25, 2022
- Analyst Says This Small Cap Stock Might Be 'Game Changer' In Bispecific T Cell Engagers SpaceVandana Singh - Oct 25, 2022, 2:26PM
- Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022Benzinga Insights - Oct 25, 2022, 10:19AM
- HC Wainwright & Co. Initiates Coverage On LAVA Therapeutics with Buy Rating, Announces Price Target of $9Benzinga Newsdesk - Oct 25, 2022, 6:13AM
Tuesday, September 27, 2022
- Snap To Surge Around 20%? Here Are 5 Other Price Target Changes For TuesdayLisa Levin - Sep 27, 2022, 7:09AM
- Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From YesterdayLisa Levin - Sep 27, 2022, 5:15AM
- SVB Leerink Maintains Outperform on LAVA Therapeutics, Raises Price Target to $28Benzinga Newsdesk - Sep 27, 2022, 4:27AM
Monday, September 26, 2022
- Nasdaq Turns Lower; Crude Oil Drops SharplyLisa Levin - Sep 26, 2022, 2:49PM
- Why LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day SessionLisa Levin - Sep 26, 2022, 2:05PM
- Dow Drops Over 100 Points; Crude Oil Rises Over 1%Lisa Levin - Sep 26, 2022, 12:10PM